Ingen Debuts Medical Products to U.S. Army

KGMA Business Solutions Tradeshow Line-Up

YUCAIPA, Calif., July 7, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.

Ingen will debut its new Smart Nasal Cannula on August 10-11, 2010 at the 13th Annual Force Health Protection Conference (FHP) in Phoenix, Arizona; and again on September 8th, 2010 at the Fort Detrick Vendor Day in Frederick, Maryland.

The FHP Conference provides a venue to educate attendees about health promotion, disease and injury prevention, health risks from occupational and environmental health threats and zoonotic diseases, and related preventive medicine and public health topics in garrison and deployed settings. This event will include representatives from DoD, VA and other U.S. Government agencies, academia, industry partners, and allied nations.

Fort Detrick Vendor Day will host the Defense Medical Materiel Program Office (DMMPO), U.S. Army Medical Materiel Agency (USAMMA), the Naval Medical Logistics Command (NAVMEDLOGCOM), the Air Force Medical Evaluation Support Activity (AFMESA), the Air Force Medical Logistics Office (AFMLO), and the U.S. Marine Corp Systems Command. The focus of this year's venue is on "new" products.

"KGMA Business Solutions has structured an aggressive tradeshow schedule while they work at closing $1.4M in government purchases," said Chairman and CEO Scott R. Sand. "Our marketing program is targeted for $11M in the 2010 fiscal year sales."

http://www.eventsinamerica.com/events/13th_annual_force_health_protection_conference/ev4a9c3043dc273/

http://www.detrick.army.mil/services/vendorday.cfm

http://www.ingen-tech.com/

http://www.smartnasalcannula.com/

http://www.ingenpulseoximeter.com/

About Ingen:


Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.


The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472


Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.